Cargando…

Taking on SARS-CoV-2

A new study sheds light on how SARS-CoV-2 influences the way natural killer cells can recognize and kill infected cells.

Detalles Bibliográficos
Autores principales:	Kučan Brlić, Paola, Brizić, Ilija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239673/ https://www.ncbi.nlm.nih.gov/pubmed/35762571 http://dx.doi.org/10.7554/eLife.80552

Ejemplares similares

Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion
por: Strazic Geljic, Ivana, et al.
Publicado: (2020)

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
por: Chaouat, Abigael E., et al.
Publicado: (2022)

Neutralizing SARS-CoV-2
por: Poeschla, Eric
Publicado: (2020)

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins
por: Pribanić Matešić, Marina, et al.
Publicado: (2022)

A lipidomic view of SARS-CoV-2
por: Ebrahimi, Kourosh H., et al.
Publicado: (2021)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021)

SARS-CoV-2 uses CD4 to infect T helper lymphocytes
por: Brunetti, Natalia S, et al.
Publicado: (2023)

Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
por: Silverstein, Noah J, et al.
Publicado: (2022)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19
por: Zhao, Guolian, et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022)

Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology
por: Raha, Animesh Alexander, et al.
Publicado: (2020)

Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection
por: Winkler, Martin Sebastian, et al.
Publicado: (2021)

Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition
por: Nkosi, Thandeka, et al.
Publicado: (2022)

Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis
por: Hober, Andreas, et al.
Publicado: (2021)

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Mohandas, Sindhu, et al.
Publicado: (2023)

Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy
por: Inal, Jameel M.
Publicado: (2020)

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway
por: Khan, Shahanshah, et al.
Publicado: (2021)

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
por: Salina, Ana CG, et al.
Publicado: (2022)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
por: Hawman, David W, et al.
Publicado: (2022)

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
por: Verstegen, Niels JM, et al.
Publicado: (2022)

Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2
por: Huntington, Kelsey E, et al.
Publicado: (2021)

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
por: Gawish, Riem, et al.
Publicado: (2022)

Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection
por: Garrett, Meghan E, et al.
Publicado: (2022)

SARS-CoV-2-specific CD4(+) and CD8(+) T cell responses can originate from cross-reactive CMV-specific T cells
por: Pothast, Cilia R, et al.
Publicado: (2022)

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
por: Gálvez, Nicolás MS, et al.
Publicado: (2022)

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
por: Fielding, Ceri Alan, et al.
Publicado: (2022)

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
por: Zhang, Jing, et al.
Publicado: (2022)

mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
por: Neidleman, Jason, et al.
Publicado: (2021)

The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021)

Atypical presentation of SARS-CoV-2 infection in male genitalia
por: Özveri, Hakan, et al.
Publicado: (2020)

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study
por: Brlić, Paola Kučan, et al.
Publicado: (2022)

Acute testicular infarction in the setting of SARS-CoV-2 infection and diabetic vasculopathy
por: Zhang, Tenny R., et al.
Publicado: (2023)

Fibrin microthrombi in bladder urothelium after SARS-CoV-2 infection: Case report
por: Hoang Roberts, Ly, et al.
Publicado: (2023)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Control of RNA viruses in mosquito cells through the acquisition of vDNA and endogenous viral elements
por: Tassetto, Michel, et al.
Publicado: (2019)

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oongappmatpogi9mntsiih24eh